Cargando…
Cardiac safety of off-label COVID-19 drug therapy: a review and proposed monitoring protocol
More than 2,000,000 individuals worldwide have had coronavirus 2019 disease infection (COVID-19), yet there is no effective medical therapy. Multiple off-label and investigational drugs, such as chloroquine and hydroxychloroquine, have gained broad interest due to positive pre-clinical data and are...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7235441/ https://www.ncbi.nlm.nih.gov/pubmed/32372695 http://dx.doi.org/10.1177/2048872620922784 |